Under SAMSHA oversight, Advocates for Human Potential, Inc. (AHP) in partnership with the Center for Practice Innovations (CPI) work together to develop simple, practical decision support resources for clinicians through the
Recovery to Practice (RTP) initiative. RTP provides training and technical assistance to enhance recovery-oriented practices among the behavioral health and primary care workforce. Trainings focus on merging clinical practice guidance with recovery-oriented approaches, holistic integrated health care, shared decision making, trauma-informed care, and cultural relevance.
SAMHSA's Recovery to Practice (RTP) is pleased to introduce the new on-demand continuing medical education (CME) course:
Clozapine as a Tool in Mental Health Recovery
This one-hour course offers information and resources for physicians, clinicians, and other practitioners serving people experiencing psychotic symptoms who are considering exploring the use of clozapine. Through a "virtual grand rounds," this course will help you better understand the FDA guidelines, which individuals might benefit from clozapine, the risks and benefits of the medication, and how to engage in shared decision-making with individuals about using clozapine.
In this course, you'll meet Robert, a young man with hopes of attending college and becoming a writer, who also struggles with psychotic symptoms. The course will explore the scientific evidence and best practices for how clozapine may be used as a tool to help him move closer to achieving his goals; as well as how to engage with Robert in a strengths-based, recovery-oriented way.
The faculty are national experts in recovery-oriented pharmacology, who present tips on how to engage with individuals experiencing psychotic symptoms and using clozapine as an effective tool to help them move closer to achieving their goals.
Professionals will receive 1 CME credit for participation in this course. (CME provided by American Academy of Family Physicians.)
After viewing, learners will be able to:
- Explain some of the benefits of initiating clozapine for psychotic symptoms and advancing recovery.
- Articulate how shared decision-making has a role in initiating clozapine.
- Describe the clozapine Risk Evaluation and Mitigation Strategy (REMS).
- Identify methods for recognizing and managing benign ethnic neutropenia, or BEN, for primary care and psychiatry providers.
|Anne Hackman, M.D., Associate Professor of Psychiatry, University of Maryland School of Medicine
|Stephanie Le Melle, M.D., M.S., Associate Professor of Clinical Psychiatry, Columbia University School of Medicine
|Ikwunga Wonodi, M.B.B.S., Associate Professor of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine